Resistance Maintained in Digital Organisms despite
Guanine/Cytosine-Based Fitness Cost and Extended De-Selection: Implications
to Microbial Antibiotics Resistance
- URL: http://arxiv.org/abs/2302.13897v1
- Date: Sun, 19 Feb 2023 11:40:36 GMT
- Title: Resistance Maintained in Digital Organisms despite
Guanine/Cytosine-Based Fitness Cost and Extended De-Selection: Implications
to Microbial Antibiotics Resistance
- Authors: Clarence FG Castillo, Zhu En Chay, Maurice HT Ling
- Abstract summary: The aim of this study is to examine the rate of gain and loss of resistance where fitness costs have incurred in maintaining resistance.
Our results showed that GC-content based fitness cost during de-selection by removal of antibiotic-induced selective pressure portrayed similar trends in resistance compared to that of no fitness cost.
- Score: 0.0
- License: http://creativecommons.org/licenses/by-sa/4.0/
- Abstract: Antibiotics resistance has caused much complication in the treatment of
diseases, where the pathogen is no longer susceptible to specific antibiotics
and the use of such antibiotics are no longer effective for treatment. A recent
study that utilizes digital organisms suggests that complete elimination of
specific antibiotic resistance is unlikely after the disuse of antibiotics,
assuming that there are no fitness costs for maintaining resistance once
resistance are established. Fitness cost are referred to as reaction to change
in environment, where organism improves its' abilities in one area at the
expense of the other. Our goal in this study is to use digital organisms to
examine the rate of gain and loss of resistance where fitness costs have
incurred in maintaining resistance. Our results showed that GC-content based
fitness cost during de-selection by removal of antibiotic-induced selective
pressure portrayed similar trends in resistance compared to that of no fitness
cost, at all stages of initial selection, repeated de-selection and
re-introduction of selective pressure. Paired t-test suggested that prolonged
stabilization of resistance after initial loss is not statistically significant
for its difference to that of no fitness cost. This suggests that complete
elimination of specific antibiotics resistance is unlikely after the disuse of
antibiotics despite presence of fitness cost in maintaining antibiotic
resistance during the disuse of antibiotics, once a resistant pool of
micro-organism has been established.
Related papers
- Relation-Aware Equivariant Graph Networks for Epitope-Unknown Antibody Design and Specificity Optimization [61.06622479173572]
We propose a novel Relation-Aware Design (RAAD) framework, which models antigen-antibody interactions for co-designing sequences and structures of antigen-specific CDRs.
Furthermore, we propose a new evaluation metric to better measure antibody specificity and develop a contrasting specificity-enhancing constraint to optimize the specificity of antibodies.
arXiv Detail & Related papers (2024-12-14T03:00:44Z) - Opponent Shaping for Antibody Development [49.26728828005039]
Anti-viral therapies are typically designed to target only the current strains of a virus.
therapy-induced selective pressures act on viruses to drive the emergence of mutated strains, against which initial therapies have reduced efficacy.
We build on a computational model of binding between antibodies and viral antigens to implement a genetic simulation of viral evolutionary escape.
arXiv Detail & Related papers (2024-09-16T14:56:27Z) - Enhancing Antibiotic Stewardship using a Natural Language Approach for Better Feature Representation [0.0]
The rapid emergence of antibiotic-resistant bacteria is recognized as a global healthcare crisis.
This study explores the use of clinical decision support systems to improve antibiotic stewardship.
EHR systems present numerous data-level challenges, complicating the effective synthesis and utilization of data.
arXiv Detail & Related papers (2024-05-30T18:53:53Z) - AntiBARTy Diffusion for Property Guided Antibody Design [0.0]
We train an antibody-specific language model, AntiBARTy, based on BART (Bidirectional and Auto-Regressive Transformer) and use its latent space to train a property-conditional diffusion model for guided IgG de novo design.
As a test case, we show that we can effectively generate novel antibodies with improved in-silico solubility while maintaining antibody validity and controlling sequence diversity.
arXiv Detail & Related papers (2023-09-22T18:30:50Z) - Spatial-Temporal Networks for Antibiogram Pattern Prediction [30.552245946539994]
Antibiograms help clinicians understand regional resistance rates and select appropriate antibiotics in prescriptions.
In practice, significant combinations of antibiotic resistance may appear in different antibiograms, forming antibiogram patterns.
We propose a novel problem of antibiogram pattern prediction that aims to predict which patterns will appear in the future.
arXiv Detail & Related papers (2023-05-02T20:01:48Z) - xTrimoABFold: De novo Antibody Structure Prediction without MSA [77.47606749555686]
We develop a novel model named xTrimoABFold to predict antibody structure from antibody sequence.
The model was trained end-to-end on the antibody structures in PDB by minimizing the ensemble loss of domain-specific focal loss on CDR and the frame-aligned point loss.
arXiv Detail & Related papers (2022-11-30T09:26:08Z) - Incorporating Pre-training Paradigm for Antibody Sequence-Structure
Co-design [134.65287929316673]
Deep learning-based computational antibody design has attracted popular attention since it automatically mines the antibody patterns from data that could be complementary to human experiences.
The computational methods heavily rely on high-quality antibody structure data, which is quite limited.
Fortunately, there exists a large amount of sequence data of antibodies that can help model the CDR and alleviate the reliance on structure data.
arXiv Detail & Related papers (2022-10-26T15:31:36Z) - Joint Application of the Target Trial Causal Framework and Machine
Learning Modeling to Optimize Antibiotic Therapy: Use Case on Acute Bacterial
Skin and Skin Structure Infections due to Methicillin-resistant
Staphylococcus aureus [5.611469725376418]
We develop a machine learning model of mortality prediction and ITE estimation for patients with acute bacterial skin and skin structure infection (ABSSSI) due to methicillin-resistant Staphylococcus aureus (MRSA)
First, we use propensity score matching to emulate the trial and create a treatment randomized (vancomycin vs. other antibiotics) dataset.
Next, we use this data to train various machine learning methods (including boosted/LASSO logistic regression, support vector machines, and random forest) and choose the best model in terms of area under the receiver characteristic (AUC) through bootstrap validation.
arXiv Detail & Related papers (2022-07-15T13:08:15Z) - Machine learning techniques to identify antibiotic resistance in
patients diagnosed with various skin and soft tissue infections [1.897172519574925]
Skin and soft tissue infections (SSTIs) are among the most frequently observed diseases in ambulatory and hospital settings.
Resistance of diverse bacterial pathogens to antibiotics is a significant cause of severe SSTIs.
We developed machine learning (ML) models to predict antimicrobial resistance using antibiotic susceptibility testing data.
arXiv Detail & Related papers (2022-02-28T01:08:02Z) - Timely Tracking of Infection Status of Individuals in a Population [70.21702849459986]
We consider real-time timely tracking of infection status of individuals in a population.
In this work, a health care provider wants to detect infected people as well as people who recovered from the disease.
arXiv Detail & Related papers (2020-12-24T18:49:22Z) - Accelerating Antimicrobial Discovery with Controllable Deep Generative
Models and Molecular Dynamics [109.70543391923344]
CLaSS (Controlled Latent attribute Space Sampling) is an efficient computational method for attribute-controlled generation of molecules.
We screen the generated molecules for additional key attributes by using deep learning classifiers in conjunction with novel features derived from atomistic simulations.
The proposed approach is demonstrated for designing non-toxic antimicrobial peptides (AMPs) with strong broad-spectrum potency.
arXiv Detail & Related papers (2020-05-22T15:57:58Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.